Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vulcan Two Group PLC ( (GB:VUL) ) has shared an update.
Vulcan Two Group plc has conditionally raised £40 million in an oversubscribed placing of 20 million new shares at 200 pence each, attracting strong backing from both existing and new institutional investors. The net proceeds, together with existing cash, will fund initial acquisition payments, working capital for the enlarged group, further bolt-on deals and support future trading growth.
Several substantial shareholders, including Octopus Investments, Gresham House Asset Management and Dowgate Group, participated in the placing, with the board deeming their involvement fair and reasonable under AIM rules. Completion of the acquisitions and the placing remains subject to shareholder approval at a general meeting scheduled for 17 March 2026, with an admission document and meeting notice being sent to investors and posted on the company’s website.
More about Vulcan Two Group PLC
Vulcan Two Group plc is a UK-based company seeking to build the country’s leading regulated ePharmacy via a buy-and-build strategy. The business focuses on acquiring and integrating online pharmacy and related healthcare assets, targeting scalable digital prescription and medicines services for the UK market.
Average Trading Volume: 5,262
Technical Sentiment Signal: Strong Sell
For an in-depth examination of VUL stock, go to TipRanks’ Overview page.